<ul id="eack0"><dfn id="eack0"></dfn></ul>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><input id="eack0"></input></strike>
    
    
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"></strike>
    歡迎來到上海通蔚!

    021-54845833/15800441009

    品質(zhì)保證 · 通蔚試劑

    當(dāng)前位置: 首頁 > 科研產(chǎn)品 > 科研抗體 > 其他抗體 > VWA5A抗原(重組蛋白)

    產(chǎn)品中心

    最新產(chǎn)品

    • VWA5A抗原(重組蛋白)

      規(guī)格:
      價(jià)格:
      • 品牌 : 通蔚生物
      • 目錄號 : TW17845
      • 應(yīng)用 : 僅供科研使用
      • 貨期 : 現(xiàn)貨
      • 規(guī)格 :1mg/100ug
    • 商品詳情
    • 參考文獻(xiàn)
    • 說明書下載
    • 商品評論0
    • 相關(guān)產(chǎn)品

    中文名稱:VWA5A抗原(重組蛋白)

    英文名稱 VWA5A Antigen (Recombinant Protein)

    別     名: BCSC1; BCSC-1; LOH11CR2A

    儲      存: 冷凍(-20℃)

    相關(guān)類別 抗原

    概  述

    Fusion protein corresponding to C terminal 250 amino acids of human VWA5A


    技術(shù)規(guī)格:

    Full name:

    von Willebrand factor A domain containing 5A

    Synonyms:

    BCSC1; BCSC-1; LOH11CR2A

    Swissprot:

    O00534

    Gene Accession:

    BC001234

    Purity:

    >85%, as determined by Coomassie blue stained SDS-PAGE

    Expression system:

    Escherichia coli

    Tags:

    His tag C-Terminus, GST tag N-Terminus

    Background:

    VWA5A (von Willebrand factor A domain containing 5A), also known as BCSC-1 (breast cancer suppressor candidate 1) or LOH11CR2A (loss of heterozygosity 11 chromosomal region 2 gene A protein), is a 786 amino acid protein containing one VIT domain and one VWFA domain. VWA5A is expressed at low levels in various tissues, with no expression found in 80% of tumor cell lines. Likely acting as a tumor suppressor gene, deletion of VWA5A leads to loss of heterozygosity (LOH) in breast and ovarian tumors, and may have an important role as a potential gene therapy target. Abnormal expression of VWA5A may lead to an increase in adhesion of CNE-2L2 cells associated with an increase in expression of E-cadherin, alpha-catenin, and p53, resulting in a decrease of malignant activity in cells with ectopic expression of VWA5A.


    產(chǎn)品掃碼查看詳情
    手機(jī)掃描查看
    <ul id="eack0"><dfn id="eack0"></dfn></ul>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><input id="eack0"></input></strike>
    
    
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"></strike>